引用本文:叶建新,张 敏,仲来福.NMDA体内抗肿瘤作用的试验研究[J].大连医科大学学报,2000,22(2):.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载  
分享到: 微信 更多
NMDA体内抗肿瘤作用的试验研究
叶建新, 张 敏, 仲来福
大连医科大学卫生学教研室,辽宁 大连116027
摘要:
旨在评价新铂类化合物N-烷基亚胺二乙酸二氨铂(Ⅱ)配合物(NMDA)体内抑瘤作用。方法:采用小鼠移植性腹水瘤和实体瘤模型,检测生命延长率或瘤重抑制率。结果显示,对小鼠移植性腹水瘤艾氏腹水癌有较高疗效,当剂量为75 mg/kg时,生命延长率达112.3%;当剂量为50、75mg/kg时,对小鼠移植性实体瘤S180的瘤重抑制率分别为30.6%和43.9%;对小鼠移植性实体瘤G422有轻微的抑制作用;对肝癌H22无抑制作用
关键词:  延长率  卡铂
DOI:10.11724/jdmu.2000.02.06
分类号:R114
基金项目:
Investigation of antitumor efficacy of NMDA on transplanted tumors in mice
YE Jian xin, ZHANG Min, ZHONG Lai fu
(Department of Hygiene,Dalian Medical University,Dalian 116027,China)
Abstract:
To investigate antitumor efficacy of a new Pt coordination complex NMDA,the antitumor tests were made in mouse bearing tumor. The results showed that the increase in life span of ascites tumor beating mice was 112.3% at a dose of 75mg/kg(ip).The growth of S180 solid sarcoma was also significantly suppressed by ip NMDA.At the dose of 50 or 75g/kg(ip),the inhibition rates were 30.6 and 43.9%, respectively.These results indicate that NMDA is a potential antitumor drug
Key words:  NMDA  increase in life span  carboplatinum